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Abstract 
The identification of drug related problems is the focus of the assessment and the last decision made in that step 
of the patient care process. Although drug therapy problem identification is technically part of the assessment 
process, it represents the truly unique contribution made by pharmaceutical care practitioners. It is also a 
common scenario in chronic non communicable diseases, like cardiovascular diseases. The objective of the 
research was to determine the prevalence of drug therapy problems among adult ambulatory patients with 
cardiovascular diseases in Gebretsadik Shawo General Hospital (GSGH). Hospital based prospective cross 
sectional study design was employed. 130 adult patients with cardiovascular disease who fulfilled the inclusion 
criteria were included. The principal investigator was involved in collecting the data. The data was analyzed 
manually using scientific calculator. A total of 163 DRPs were identified with the mean number of 1.5±0.8. 
While the DRP per patient was 1.08±0.75.Most of the patients (108, 72%) had drug related problem, of which 
drug indication related problems constituted the highest part 64(39.26%). Followed by non compliance to drugs 
46(28.22 %), drug safety (32, 19.63%) and drug effectiveness (21, 12.89%) related issues. 
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Acronyms and abbreviations 
ADR------------------------Adverse Drug Reaction 
CCB-------------------------Calcium Channel Blockers 
DRP-------------------------Drug Related Problems 
FHRH-----------------------Felege Hiwot Referral Hospital 
FMHACA-----------------Food Medicine and Health care Administration and Control Authority  
GSGH-----------------------Gebretsadik Shawo General Hospital 
JUSH------------------------Jimma University Specialized Hospital 
MOH-----------------------Ministry Of Health 
NSAIDs---------------------Non Steroidal Anti-Inflammatory Drugs 
 
Introduction  
The increasing number of available drugs and drug users as well as more complex drug regimens led to more 
side effects and adverse drug reactions and complicates follow-up. The availability of large number of medicines 
and the constant efflux of new information make them practically impossible for any health care professional to 
be updated in all aspects. 
Helper and strand define pharmaceutical care as, ‘the responsible provision of drug therapy for the 
purpose of achieving definite outcomes which improve the patient’s quality of life’ (Hepler C. et al, 1990). 
Hepler used the terms like drug-related problem, drug treatment failure, and pharmacotherapeutic problem in one 
article to describe DRPs 
According to Pharmaceutical Care Network Europe (PCNE) classification volume 6.2, a drug related 
problem is ‘an event or circumstance involving drug therapy that actually or potentially interferes with desired 
health outcomes (Zuidlaren , 2010). 
According to Robert J. Cipolle text book of pharmaceutical care practice (3rd edition), DRPs are 
classified into seven classes, including: Need additional drug therapy, unnecessary drug therapy, ineffective drug, 
too low or too high dosage, adverse drug reactions, and noncompliance (Cipolle R. 2nd ed.). 
Drug related problems are relatively common in hospitalized patients and can result in patient morbidity 
and mortality, and increased costs besides their alarming rise among patients who are on chronic care follow up 
(Gaziano T., 2009).  
Cardiovascular diseases are a group of disorders of the heart and blood vessels. Most of patients with 
cardiovascular disease can be treated and managed by proper follow and check up in an outpatient department, 
though these CVDs accounts for 7-10% of all adult medical admissions in African hospitals (Van den bemt P. et 
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al ,2000).  
Numbers of patients who are on follow up have a diverse drug related needs and problems which 
require intervention to reduce development of complications at home and thereby improve quality of life of 
patients with CVD. (Braun L. et al, 2012). 
Drug related problems are of a major concern in health care because of increased cost, morbidity and 
mortality. The cost of drug related morbidity and mortality exceeded $177.4 billion in 2000 of total costs, 
followed by long-term-care admissions, which accounted for 18% ($32.8 billion) (Andreaza R. et al, 2011). 
DRP is associated with prolonged length of stay, increased economic burden, and an almost 2-fold 
increased risk of death. Drug related problems are major reasons for admission ranging from the emergency 
ward up to the intensive care unit, despite their preventability. (Stafford A. et al, 2009). 
The study tried to find out drug related problems among patients with cardiovascular diseases. 
Furthermore there are no studies conducted in the area. Therefore, the study findings will help in devising 
strategies to optimize proper drug use. 
Moreover the finding of this study will be important source of information which might support the 
decision makers of the institution as well as other stake holders to design appropriate programs to deal with the 
problem. It will also lay background to researchers to conduct further research on the issue. 
Objectives 
General objective:   
 To determine drug therapy problems among adult patients with cardiovascular diseases attending a 
chronic care unit at GSGH.  
Specific objectives 
 To determine the prevalence of DRPs 
 To identify the common types of DRPs encountered 
 To identify drugs involved in  DRPs 
Methods and materials 
Study area and period 
The study was carried out among adult ambulatory patients with CVD in GSGH. GSGH is one of the general 
Hospitals in southern Ethiopia. It is found in Bonga town which is located 444km south west of Addis Ababa, 
the capital city of Ethiopia. The hospital has various units including the inpatient ward with a total of 120 beds. It 
has 52 technical and 103 administrative staffs. The hospital serves the people of Bonga town, the administrative 
town of Kafa zone, and 10 woredas under its administration as a general hospital. The study was conducted from 
March 28 to April 12 2015 GC. 
Study design   
 A hospital based prospective cross sectional study design was employed.  
Source population 
All ambulatory patients with CVD in the chronic care unit. 
Study population  
All adult patients with CVD on follow up in chronic care unit 
Inclusion criteria   
 Patients following chronic care unit for cardiovascular diseases. 
Exclusion criteria   
 Those not willing to participate 
Sample Size and Sampling Technique 
Based on a study conducted in Felege Hiwot referral hospital regarding the prevalence of DTP in 2014, the 
prevalence rate of DTP among CVD patients was found to be 90%.so we can take the 90% as a previous 
prevalence rate. 
                                            n=
2
2
d
pqZ
 
  
n= the minimum sample size  
Z=reliability coefficient for desired interval (CI) for 95% = 1.96  
p = proportion of self-medication = 90% (0.9) 
q= 1-p = 0.1 
d= desired interval (degree of precision) = 5% (0.05) 
Then n= 
2
2
)05.0(
)9.01(9.0)96.1( −
 = 138 
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Since the study population is less than 10,000 correction formula was used to get the final sample size (nf). 
Nf=n/1+n/N =138/1+138/900=120 
Where 
nf= final sample size, N=total study population 
10% non response was added, so sample size will be 132. Therefore sample size of 132 was considered.  
Convenience sampling was employed to interview the patients. 
Data collection tools and procedure 
Data collection was undertaken during the study period. The data was collected through medical record reviews 
of patients using a prepared standard checklist and structured questionnaire. DTPs were identified by evaluating 
patient card by the use of checklist and the appropriateness of prescriptions in terms of indication, dosage, safety 
and efficacy.  
Issues related with adherence were assessed by the questionnaire. The existence of DRP was identified using 
Ethiopian treatment guideline (2014 version) and guideline of American heart association (AHA)(2013 version). 
 Variables   
Independent variables 
•  Sociodemographic characteristics 
• Social drug use 
• Traditional medicine use 
• Type of CVD 
• Presence of co morbidities 
• Number of drugs 
Dependent variable 
• Presence  of  DTP 
Ethical consideration  
Formal letter was obtained from the department of Pharmacy and the letter was given to the Hospital (GSGH). 
Written consent was taken in the form of signature so that patients were willing to give their medical information. 
Patients were assured that lack of willingness to involve in the study would not affect the service they get from 
the hospital. Confidentiality of patient data was ensured, thus name and address of the patient was not recorded 
in the data collection material. 
Operational definition 
 A drug therapy problem: is when there is an occurrence of one of the problems related to indication, 
effectiveness, safety and compliance. 
 Adverse drug reaction: is any potential, harmful and unintended effect associated with the drug during 
the medication use process. 
 Co-morbid condition: a disease condition other than CVD 
 Cardiovascular disease: are disease of the heart and blood vessels 
 Adherence: is drug taking behavior of a patient and when a patient says no at least for one of the 
question, he/she is non-compliant.  
Results   
Socio-demographic characteristics of patients in GSGH.  
Total of 130 patients with CVD were included making a response rate of 98.5%. The study consisted of 
68(52.30%) females. The mean age of the patients was 50±15.8 years with the minimum age of 18 and the 
maximum of 85 years. Around 98(75.3%) patients were Kafa nationals.  
Majority of the patients were followers of orthodox Christianity and live in urban areas and have an 
average monthly income each constituting 78(60%) of the study participants.  
Around 101(77.70%) the patients used at least one of the social drugs (coffee, tea, chat, alcohol or 
cigarette) where coffee was the most consumed social drug (76, 75.25%) (Table-1) 
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Table 1-sociodemographic characteristics of adult ambulatory patients with CVDs attending the chronic care unit 
of GSGH, 28th march-12th April, 2015 (n=130) 
Variables  Response  Frequency  Percent  
1.sex  Male 62 47.7% 
Female 68 52.3% 
2.Age in years  18-24 6 4.64% 
25-34 24 18.45% 
35-44 14 10.74% 
45-54 22 16.93% 
55-64 32 24.62% 
≥65 32 24.62% 
3.Marital status Single 24 18.45% 
Married 87 66.91% 
Divorced 6 4.64% 
Widowed 13 10.0% 
4.Religion  Orthodox 78 60% 
Muslim 38 29.23% 
Protestant 14 10.77% 
5.Residence  Urban 78 60% 
Rural 52 40% 
6.Ethnicity 
    
 
Kaffa 98 75.38% 
Amhara 16 12.30% 
Oromo 10 7.68% 
Others 6 4.64% 
7.Education  Illiterate 52 40% 
Elementary 36 27.69% 
High school 24 18.46% 
College and above 18 13.85% 
8.Occupation 
 
 
Farmers 
Governmental  
56 
44 
43.08% 
33.85% 
Private 16 12.30% 
Student 9 6.92% 
Others 5 3.85% 
9.Monthly income 446-1200 
1201-2500 
2501-3500 
12 
28 
78 
9.23% 
21.54% 
60% 
˃3501 12 9.23% 
10.Social drug use 
     (n=101) 
Coffee 76 75.25% 
Tea 10 9.9% 
Alcohol 8 7.92% 
Chat 5 4.95% 
Cigarette 2 1.98% 
Specific types of CVDs and common co-morbid conditions 
The most common cardiovascular diseases encountered during the data collection period were hypertension (84, 
64.6%) and congestive heart failure (40, 30.77%).Out of 130 patients around 86(66.15%) experienced at least 
one co morbid conditions during the study period.  
The most commonly encountered co-morbid conditions were community acquired 
pneumonia(32,37.20%),acute febrile illness(21,24.45%),dyspepsia(18,20.95%) and upper respiratory tract 
infection(15,17.40%) A maximum of two number of co morbidities were observed, while the mean number of co 
morbidity was 1.4±0.6. 
Commonly prescribed medications among patients with CVD in GSGH 
A total of 282 numbers of cardiovascular drugs were used to manage these cardiovascular problems among 144 
patients. The mean number of drug was 1.9 ±1.08 per patient. A maximum of five numbers of drugs were 
prescribed. ACEI inhibitors (66, 44%) and Calcium channel blockers (66, 44%) were the most commonly used 
drugs. Besides around 6(4%) of CHF patients were not given any medication 
The most commonly prescribed groups of drugs for management of co-morbid condition were 
antibiotics(90,48.93%),Gastrointestinal drugs(36,19.35),Non steroidal anti inflammatory 
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drugs(NSAIDs)(33,17.74%) and Vitamins and Minerals(26,13.98%) . 
Prevalence of DRPs among patients with CVD in GSGH 
A total of 108 patients had one or more DTPs. The prevalence of DTPs in the current study is 72%. There was a 
total of 163 DTPs identified. The mean number of DTP was 1.5±0.8 per patient. The maximum number of DTPs 
was three. Most of the patients (56, 51.85%) had two DTPs. (fig 1) 
 “Fig-1” prevalence of DRPs among adult ambulatory patients with CVDs attending the chronic care unit of 
GSGH, 28th march-12th April,2015 
72%
28%
Prevalence of DRPs
DRPs
No DRPs
 
Common types of DRPs among patients with CVD in GSGH 
There were 64 (39.26%), 46 (28.22%), 32 (19.63%) and 21 (12.89%) number of DTPs obtained representing 
indication, compliance, safety and effectiveness related problems respectively. (fig 2) 
 
“Fig-2” percentages of DTPs among adult ambulatory patients with CVDs attending the chronic care unit of 
GSGH,28th march-12th April,2015 
Most of the indication problem was need additional drug therapy (54,33.12%).  There were 21 (12.89%) 
numbers of DTPs among effectiveness related problems; where effective drug available (17, 10.42%) and 
inappropriate frequency (4, 2.45%) were the common DTPs respectively. Around 32 (19.63%) number of DTPs 
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were obtained regarding safety, where 21 (12.88%) and 8(4.90%) number of patients had contraindications and 
inappropriate frequency respectively. In an effort to assess the compliance issue, majority (29,17.80%) of 
patients forgot  taking medication at least once in their treatment course. 
Majority of the indication problem was need additional drug therapy. Ineffective drug therapy was 
common among effectiveness related issues followed by contraindication under safety issue and forgetting to 
take the medication was prominent in compliance related problems(table-2) 
Table-2 Specific DTPs identified among adult ambulatory patients with CVDs attending the chronic care unit of 
GSGH,28th March-12th April,2015(n=108) 
DRP involved Type of DRP                     Reasons  Freq/%    Total  
 
 
 
Indication 
        
 
1.Unnecessary 
drug therapy 
a)Multiple drug therapy used 
b)Non drug therapy is more appropriate 
3(1.85) 
7(4.30) 
   
 10(6.14%) 
2.Needs 
additional drug 
therapy 
a)Medical condition needs initiation of 
drug therapy 
b)Preventive therapy required 
c)Drug needed for synergistic effect 
11(6.74) 
 
34(20.85) 
9(5.52) 
 
 
54(33.12%) 
  Effectiveness 
           
3.Ineffective drug 
therapy 
a)More effective drug available 17(10.42) 17(10.43%) 
4.Dosage too low b)Frequency inappropriate 4(2.45) 4(2.45%) 
 
Safety 
         
5.Adverse drug 
reaction 
a)Contraindications exist 21(12.88) 21(12.88%) 
6.Dosage too 
high 
a)Too short dosing frequency 
b)Drug interaction 
8(4.90) 
3(1.84) 
11(6.75%) 
 
Compliance 
          
7.Non 
compliance 
a)Do not understand instructions 
b)Forget to take the medication 
c)Drug product is too expensive 
8(4.90) 
29(17.80) 
 9(5.52) 
 
46(28.23%) 
Drugs responsible for DRP among CV patients in GSGH 
 Generally the groups of drugs used among CV patients in GSGH were ACEIs,CCBs,Diuretics, BBs and digoxin. 
Accordingly the drugs responsible for DTP were among these groups and the common drugs responsible for 
DTP are listed below. (Table-3)  
Table-3 Most commonly encountered drugs with DTPs among adult ambulatory patients with CVDs attending 
the chronic care unit of GSGH,28th March-12th April,2015 
 
Drug/drug 
class 
Need 
additional 
therapy  
    No/% 
Unnecessary 
drug therapy 
  
No/% 
Ineffective 
drug 
 
 No/% 
Low 
dosage 
  
No/% 
  ADR 
   
 
No/% 
High 
dose 
 
No/% 
Non 
compliance 
No/% 
CCBs 3(1.84) 8(4.9)   - 2(1.22) 1(0.61) 3(1.84) 11(6.75) 
Digoxin 6(3.68) -   -     - 2(1.22) - 2(1.22) 
NSAIDs - -    -     - 21(12.88) -    - 
Diuretics  2(1.22) 2(1.22) 11(6.75) 2(1.22) 1(0.61) 5(3.06)    - 
ACEIs 5(3.06) 8(4.9) 5(3.06)     - 1(0.61)   - 1(0.61) 
Aspirin/Statin 34(20.85)    -     -     -    -   -    - 
Beta blockers 5(3.06)    - 3(1.84)     -    -   - 4(2.45) 
 
Discussion  
The most common cardiovascular disease encountered during the data collection period were hypertension 
(78,52%) and congestive heart failure (50,33.4%),where the study in Felege Hiwot referral 
hospital(FHRH)showed hypertensive heart disease (32%), rheumatic heart diseases (31.6%) and functional heart 
failure (18.4%) as a major diagnosis(Gobezie T. et al,2014). The variation might be due to the high number of 
hypertensives in the study groups. 
CAP (29.5%), AFI (19%) and dyspepsia (16.9%) were the most commonly observed co morbidities 
while in Venezuela, Urinary tract infection (13.75%)anemia (12.5%) and pneumonia (11.25%) were the common 
co morbidities(Carlos H. et al.2013). The relative similarity among these two studies can be explained by the 
higher prevalence of infection in developing countries. 
A total of 282 numbers of drugs were used to manage these cardiovascular problems among 144 
patients. The mean number of drug was 1.9 ± 1.08 per patient which is smaller than the study in  Adama, which 
had a mean of 3±1.4 number of drugs per patient(Likisa L.,2013) because  the number of patients in combination 
therapy were more numerous in Adama hospital than GSGH. 
ACEI inhibitors (44%) and Calcium channel blockers (44%) were the commonly used drugs among 
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cardiovascular patients while in Belo Horizonte, the most commonly used drugs were Diuretics (76.3%), ACE 
inhibitors (52.6%) and antibiotics (27.6%)(Yone D., 2009). This could be due to higher number of hypertensive 
patients in this study. 
Most of the patients (102,72%) had DTP, which is similar to the study by Mekonnen AB (22). A total 
of 163 numbers of DTPs were identified. The study in FHRH showed that there were 105 DTPs(Gobezie T. et 
al,2014). On the other hand a study in JUSH internal medicine ward showed, 149 DTPs(Bereket M. et al,2011) 
this variation can be due to the absence of clinical pharmacy service in the study area. 
The mean number of DTP in this study was 1.28±0.8 per patient but studies in FHRH and JUSH 
showed 1.38±0.8(Gobezie T. et al,2014) and 3.014(Bereket M. et al,2011) DTPs per patient. This is because the 
number of medications used in this study are relatively lower than the two studies. 
The major DTP type was indication (39.26%), from which need additional drug therapy was the 
common, which is similar to a study in Los angeles (Elaine L. et al ,2009) while in China  efficacy and safety 
DTP types were the common(Xiao Li, 2009); such difference can be explained with higher number of drug use 
in China  and can be due to absence of  specific and comprehensive national CVD treatment guide line in 
Ethiopia.  
Need additional drug therapy (84.37%) is one of the most common DTPs. It was also common problem 
in the FHRH(90.69%)( Gobezie T. et al,2014) and in JUSH internal medicine ward (83%)( Bereket M. et al,2011) 
and Adama(76%). This can be due to the absence of specific and comprehensive disease management guideline 
in Ethiopia. 
The common untreated indications were anemia(9) and thrombocytopenia(2) respectively. While in 
Nigeria anemia (13), hypertension (5) and urinary tract infection (3)(Lotte S. et al,2010).Anemia is common in 
both studies mainly because of the poor nutritional status of the community in Ethiopia. 
There were21(12.89%)patients with effectiveness related DTP,which is  lesser than the study by FHRH 
(31) and Mekonnen AB (22) this might be due to  the types of effectiveness related problems, where this study 
obtained only 2 types of  effectiveness related problems . 
Relatively lower number of safety related problems(19.63%)were found in this study than in JUSH 
(45.83%) (Bereket M. et al,2011) and by Mekonnen AB (31.39%)(Mekonnen A. et al,2013). This can be due 
less types of safety related issues covered with this study including dosage too high and contraindications. 
Unlike Belo Horizonte(Lotte S. et al,2010) and European studies(Ena I. et al,2013)  the highest 
percentages of safety related issues  encountered were contraindication(12.88%) and inappropriate 
frequency(4.90%).In Belo Horizonte  the common safety issue was adverse drug events while in European 
studies it was dosage too high(27.5% and 13.75%) respectively. This primarily depends on patient and drug 
related factors. 
Around 46(28.22%) number of patients were non compliant. Forget taking the medication was the 
major non-compliance issue; this can be due to patient factor. Even though different measurement of adherence 
was used, 27% of patients in Nigeria and 29% of patients in JUSH research were non compliant.  
Unlike this, studies in USA (8%), Brazil (11%) and Venezuela (13%) showed relatively lower rates of 
non compliance. This is primarily due to the awareness of population towards rational medication use and 
presence of intact drug information provision system. 
The most common drugs/groups of drugs responsible for the existence of DTP in this study were 
diuretics,CCBs and ACEIs but a study in JUSH showed antimicrobials,vitamins and minerals and antacids.This 
might be due to the existence of diverse co morbid conditions in JUSH study. 
 
Conclusions 
In the present study the most common CVDs encountered were hypertension and congestive heart failure. The 
prevalence of DTP among the studied population was high.The major DTP type was indication followed by non 
compliance, safety and effectiveness related problems.The most commonly encountered drugs with DTPs were 
Calcium channel blockers,Angiotensin converting enzyme inhibitors and Diuretics. 
 
Recommendations 
Drug therapy problem was relatively high in GSGH, so following recommendation were forwarded. 
(A) Physicians:-To prescribe medications based on the current and evidence based recommendations provided 
by the guidelines. 
(B)Pharmacist:- To deliver pharmaceutical care services for CV patients.  
(C)  Hospital:- To strengthen and support pharmaceutical care services. 
(D) MOH and FMHACA:- To establish nationwide specific and comprehensive cardiovascular disease 
management guideline. 
(E) MOH and FMHACA:- To support and facilitate the implementation of pharmaceutical care services in 
Hospitals. 
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